All News

Reimbursement

Top 10 Events in Cell & Gene Therapy 2022
18 January 2023
Top 10 Events in Cell & Gene Therapy 2022
It’s day 1 of Advanced
The Most Expensive Gene Therapy Approved by the FDA at $3.5M for Hemophilia B
23 November 2022
The Most Expensive Gene Therapy Approved by the FDA at $3.5M for Hemophilia B
Late-stage clinical trial company CellVax
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
24 August 2022
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
bluebird bio has announced that
Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
21 June 2022
Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
Lisa Deschamps, AviadoBio CEO and
POPULAR NEWS ITEMS
Image
3 February 2023

Navigating the Applications of Title21’s Manufacturing Execution System

Image
2 February 2023

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image
1 February 2023

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer

Market Access and Reimbursement Q&A with Nicola Redfern
21 June 2022
Market Access and Reimbursement Q&A with Nicola Redfern
Phacilitate's Advanced Therapies Europe speaker
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
21 June 2022
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
Market Access Report 2022
1 June 2022
Market Access Report 2022
The Phacilitate team explores market
Gene Therapy May Be More Cost Effective for Treating Haemophilia B Than Other Methods
7 June 2021
Gene Therapy May Be More Cost Effective for Treating Haemophilia B Than Other Methods
A team from St Jude
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Navigating the Applications of Title21’s Manufacturing Execution System

Image

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer